Group 4: asparagine, glutamine, serine, threonine.
A disialoundecasaccharide chain asparagine/fatty acid amide; a medical drug containing the same; and a medical drug containing disialoundecasaccharide chain asparagine.
Preferably A is aspartate or asparagine, B is valine or methionine, C is valine and D is asparagine or serine.
The method relies on interfering with an acrylamide formation pathway that begins with the amino acid asparagine.
An asparagine hydroxylase hydroxylation motif and binding motif is proposed.
Roasted coffee beans having reduced levels of acrylamide, coffee beans having reduced levels of asparagine, and an article of commerce.
The enzyme is capable of reacting on asparagine or glutamine (optionally substituted) as a substrate or is a laccase or a peroxidase.
A method of screening for agonists or antagonists of an asparagine hydroxylase is also proposed and involves mixing peptides or proteins having the hydroxylation and or the binding motif with asparagine hydroxylase and a candidate agonist or antagonist.
Novel α-amylase enzymes are disclosed in which one or more asparagine residues are substituted with a different amino acid or deleted.
The third component comprises an oligo saccharide, oligo peptide or oligo protein containing an arginine-glycine asparagine (RGD) sequence which especially increases the fixing of endothelial cells.
The medicament can also comprise conventional amino acid solution and/or glutamine or analogues thereof, L-asparagine and/or acetoacetate.
The gene asnA which encodes a prokaryotic ammonium-specific asparagine synthetase (ASN-A) can be introduced into plant cells.
More specifically, the nutritional product, in accordance with this invention, utilizes L-asparagine monohydrochloride and L-glutamine in place of L-aspartic acid and L-glutamic acid, respectively.
In this variant the threonine at position 103 of the endogenous tissue plasminogen activator is replaced by an asparagine leading to a new glycosylation site.
The invention also relates to use of an asparagine-reducing enzyme preparation for preserving the colour of the frying oil.
According to the present invention, a monoclonal antibody capable of specifically recognizing an asparagine synthase that occurs in a cell is provided.